http://www.marketwatch.com/story/antipsychotics-market-to-2017-patent-expiries-for-zyprexa-abilify-seroquel-and-geodon-and-the-launch-of-generic-versions-will-limit-commercial-opportunities-for-pipeline-molecules-2012-01-19

Links to a report for which there is a $3500 fee, but the takeaway here is the patents for Zyprexa, Abilify, Seroquel and Geodon will expire by 2017.

Advertisements